173 related articles for article (PubMed ID: 20059975)
1. Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence.
Park KH; Jang W; Kim KY; Kim JR; Cho KH
Biochem Biophys Res Commun; 2010 Feb; 392(3):295-300. PubMed ID: 20059975
[TBL] [Abstract][Full Text] [Related]
2. High-density lipoprotein (HDL) from elderly and reconstituted HDL containing glycated apolipoproteins A-I share proatherosclerotic and prosenescent properties with increased cholesterol influx.
Park KH; Cho KH
J Gerontol A Biol Sci Med Sci; 2011 May; 66(5):511-20. PubMed ID: 21415260
[TBL] [Abstract][Full Text] [Related]
3. Fructated apolipoprotein A-I exacerbates cellular senescence in human umbilical vein endothelial cells accompanied by impaired insulin secretion activity and embryo toxicity.
Park KH; Kim JY; Choi I; Kim JR; Won KC; Cho KH
Biochem Cell Biol; 2016 Aug; 94(4):337-45. PubMed ID: 27487295
[TBL] [Abstract][Full Text] [Related]
4. A zebrafish model for the rapid evaluation of pro-oxidative and inflammatory death by lipopolysaccharide, oxidized low-density lipoproteins, and glycated high-density lipoproteins.
Park KH; Cho KH
Fish Shellfish Immunol; 2011 Dec; 31(6):904-10. PubMed ID: 21906681
[TBL] [Abstract][Full Text] [Related]
5. ω-6 (18:2) and ω-3 (18:3) fatty acids in reconstituted high-density lipoproteins show different functionality of anti-atherosclerotic properties and embryo toxicity.
Park KH; Kim JY; Choi I; Kim JR; Cho KH
J Nutr Biochem; 2015 Dec; 26(12):1613-21. PubMed ID: 26363928
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of dysfunctional high-density lipoproteins using isoelectric focusing-based microfluidic device to diagnose senescence-related disease.
Jang W; Shim J; Lee DY; Dutta P; Kim JR; Cho KH
Electrophoresis; 2011 Nov; 32(23):3415-23. PubMed ID: 22134980
[TBL] [Abstract][Full Text] [Related]
7. Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity.
Yoo JA; Lee EY; Park JY; Lee ST; Ham S; Cho KH
Mol Cells; 2015 Jun; 38(6):573-9. PubMed ID: 25997739
[TBL] [Abstract][Full Text] [Related]
8. Reconstituted High-Density Lipoprotein Containing Human Growth Hormone-1 Shows Potent Tissue Regeneration Activity with Enhancement of Anti-Oxidant and Anti-Atherosclerotic Activities.
Lee EY; Kim SH; Cho KH
Rejuvenation Res; 2015 Jun; 18(3):245-56. PubMed ID: 25626070
[TBL] [Abstract][Full Text] [Related]
9. Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I.
Kim SM; Park GY; Choi I; Cho KH
Int J Mol Med; 2013 Oct; 32(4):843-50. PubMed ID: 23969702
[TBL] [Abstract][Full Text] [Related]
10. ApoA-I mutants V156K and R173C promote anti-inflammatory function and antioxidant activities.
Cho KH; Park SH; Han JM; Kim HC; Choi YK; Choi I
Eur J Clin Invest; 2006 Dec; 36(12):875-82. PubMed ID: 17087782
[TBL] [Abstract][Full Text] [Related]
11. Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state.
Jang W; Jeoung NH; Cho KH
Mol Cells; 2011 May; 31(5):461-70. PubMed ID: 21533907
[TBL] [Abstract][Full Text] [Related]
12. Structural and Functional Changes of Reconstituted High-Density Lipoprotein (HDL) by Incorporation of α-synuclein: A Potent Antioxidant and Anti-Glycation Activity of α-synuclein and apoA-I in HDL at High Molar Ratio of α-synuclein.
Cho KH
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946565
[TBL] [Abstract][Full Text] [Related]
13. Senescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activity.
Park KH; Shin DG; Kim JR; Cho KH
J Gerontol A Biol Sci Med Sci; 2010 Jun; 65(6):600-10. PubMed ID: 20421239
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
[TBL] [Abstract][Full Text] [Related]
15. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
16. Effect in vitro of apolipoprotein A-V on the structure and functions of recombinant high density lipoprotein.
Zhang X; Wang J; Chen B
Biochem Biophys Res Commun; 2010 Oct; 401(3):473-9. PubMed ID: 20869952
[TBL] [Abstract][Full Text] [Related]
17. Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein A-I dimer: evidence for restricted particle size heterogeneity.
Calabresi L; Vecchio G; Frigerio F; Vavassori L; Sirtori CR; Franceschini G
Biochemistry; 1997 Oct; 36(41):12428-33. PubMed ID: 9376346
[TBL] [Abstract][Full Text] [Related]
18. Cuban Sugar Cane Wax Alcohol Exhibited Enhanced Antioxidant, Anti-Glycation and Anti-Inflammatory Activity in Reconstituted High-Density Lipoprotein (rHDL) with Improved Structural and Functional Correlations: Comparison of Various Policosanols.
Cho KH; Baek SH; Nam HS; Kim JE; Kang DJ; Na H; Zee S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834595
[TBL] [Abstract][Full Text] [Related]
19. Enhanced delivery of rapamycin by V156K-apoA-I high-density lipoprotein inhibits cellular proatherogenic effects and senescence and promotes tissue regeneration.
Cho KH
J Gerontol A Biol Sci Med Sci; 2011 Dec; 66(12):1274-85. PubMed ID: 21964553
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of human growth hormone-2 into proteoliposome enhances tissue regeneration with anti-oxidant and anti-senescence activities.
Kim SH; Lee EY; Cho KH
Rejuvenation Res; 2015 Feb; 18(1):20-9. PubMed ID: 25400020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
